MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Ulcerative colitis, unspecified, with complications (K51.91)

HealthDay 12 January at 04.10 PM

Persistent Fluorinated Chemicals Tied to Higher Risk for Inflammatory Bowel Disease

Perfluoroalkyl and polyfluoroalkyl substance (PFAS) exposure is associated with later occurrence of inflammatory bowel disease (IBD), according to a research letter published online Dec. 26 in Clinical Gastroenterology and Hepatology.Manasi Agrawal, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and collea

HealthDay 11 December at 04.34 PM

Changes in Biochemical, Hematological Parameters Seen Before IBD Diagnosis

Changes in multiple biochemical and hematological parameters occur up to eight years before diagnosis of Crohn disease and up to three years before diagnosis of ulcerative colitis, according to a study published in the Nov. 21 issue of Cell Reports Medicine.Marie Vibeke Vestergaard, from Aalborg University in Copenhagen, Denmark, and co

HealthDay 06 November at 04.42 PM

Inflammatory Bowel Disease Increases Risk for Later Arrhythmias

Patients with inflammatory bowel disease (IBD) overall, as well as Crohn disease (CD) and ulcerative colitis (UC) individually, have an increased risk for developing later arrhythmias, according to a study published online Oct. 19 in PLOS Medicine.Jiangwei Sun, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues explo

HealthDay 02 November at 11.00 PM

FDA Approves Wezlana for Multiple Inflammatory Diseases

The U.S. Food and Drug Administration has approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases. The approval includes indications for adults with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy, active psoriatic a